Share This Page
Bulk Pharmaceutical API Sources for metoprolol tartrate
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for metoprolol tartrate
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Sigma-Aldrich | ⤷ Start Trial | M5391_SIGMA | ⤷ Start Trial |
| NovoSeek | ⤷ Start Trial | 441308 | ⤷ Start Trial |
| MP Biomedicals | ⤷ Start Trial | 190018 | ⤷ Start Trial |
| MolPort | ⤷ Start Trial | MolPort-003-983-883 | ⤷ Start Trial |
| Alsachim | ⤷ Start Trial | 1018 | ⤷ Start Trial |
| ABI Chem | ⤷ Start Trial | AC1L9AY1 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk API Sources for Metoprolol Tartrate
Metoprolol tartrate, a beta-blocker used for cardiovascular conditions, is manufactured globally. The API sourcing landscape includes a mix of large-scale pharmaceutical producers, contract manufacturing organizations (CMOs), and import/export markets. This analysis covers primary regions, key manufacturers, and market dynamics.
Major API Manufacturing Regions
- India: Leading global supplier, with prominent API manufacturers exporting to North America and Europe.
- China: Significant capacity increases over recent years, high-volume low-cost manufacturing.
- Europe: Focused on high-quality, FDA-approved sources, mainly for regulatory-compliant APIs.
- United States: Limited domestic manufacturing; primarily APIs are imported.
Key API Manufacturers and Suppliers
| Company Name | Location | Certifications | Production Capacity | Notes |
|---|---|---|---|---|
| Sagent Pharmaceuticals | India | WHO-GMP, USDMF | High | Consistent supply, regulatory compliant |
| Hetero Labs | India | USDMF, EUGMP | Large | Significant export volume, low-cost manufacturing |
| Zhejiang Huahai Pharmaceuticals | China | CE, USDMF | Large | Known for cost-effective production, compliant with US/EU regulations |
| Aurobindo Pharma | India | USDMF, EUGMP | High | Integrated R&D and manufacturing capabilities |
| Teva Pharmaceuticals | Israel | USDMF, EUGMP | High | Focus on quality, global distribution |
| Cipla | India | USDMF, EUGMP | Moderate to high | Diversified API portfolio |
Regulatory and Quality Considerations
- GMP Compliance: Most suppliers adhere to Good Manufacturing Practices, especially when targeting US and EU markets.
- Regulatory Filings: Suppliers with Active Drug Master Files (DMFs) registered with FDA or CEPs with the European Medicines Agency hold higher market relevance.
- Quality Standards: Suppliers maintaining ISO certifications and testing for residual solvents, heavy metals, and polymorphs meet stringent quality standards.
Supply Chain Dynamics
- Price Trends: Chinese APIs tend to offer lower costs compared to Indian and European sources.
- Lead Times: European and US sources often have longer lead times due to regulatory and quality assurance processes.
- Capacity Constraints: Disruptions, such as those from the COVID-19 pandemic, impacted production capacity, but recovery is now evident.
- Contract Manufacturing: Many generic drug companies rely on CMOs in Asia for large-scale API supply.
Import-Export Market
- Major Importers: US, EU, and Japan primarily import APIs from India and China.
- Exporters: India and China rank as top export sources, with India exporting approximately 60% of APIs globally (Frost & Sullivan, 2022).
Key Considerations for Procurement
- Confirm supplier regulatory filings, including USDMF/CEP.
- Ensure supplier compliance with the target market’s regulatory standards.
- Evaluate supply stability and production capacity, especially in geopolitical or pandemic-related disruptions.
- Prioritize suppliers with a track record of quality and consistent supply.
Summary
The API market for metoprolol tartrate is dominated by Indian and Chinese manufacturers providing large volumes at competitive prices. European and US sources prioritize regulatory compliance and quality. Global procurement strategies should weigh cost against regulatory requirements, supply reliability, and quality assurance.
Key Takeaways
- Indian and Chinese suppliers dominate global API sourcing for metoprolol tartrate.
- Regulatory compliance (USDMF, CEP) influences supplier selection for regulated markets.
- Cost advantages from China are tempered by longer lead times and quality assurance needs.
- European sources focus on high compliance standards but have limited capacity.
- Supply disruptions are gradually resolving, with China and India resuming steady production.
FAQs
1. Which countries are the top suppliers of metoprolol tartrate API?
India and China lead production and export, with India accounting for approximately 60% of global API exports.
2. How do regulatory standards influence sourcing decisions?
Suppliers with USDMFs or CEPs are preferred for US and EU markets due to compliance requirements, ensuring regulatory approval and quality.
3. Are Chinese API suppliers reliable?
Many Chinese suppliers have large capacities and meet international standards, but quality and regulatory compliance vary. Verification and audits are recommended.
4. What are the primary cost considerations in sourcing API?
Cost differential favors Chinese manufacturers, but factors include lead time, regulatory compliance costs, and quality assurance.
5. How has COVID-19 impacted API supply chains?
Disruptions caused capacity constraints; supplies are stabilizing but require ongoing supplier audits and contingency planning.
References
- Frost & Sullivan. (2022). Global Pharmaceutical API Market Report.
- U.S. Food and Drug Administration. (2023). Drug Master Files Database.
- European Medicines Agency. (2023). Certified Copies of EUDMF and CEPs.
More… ↓
